APA (7th ed.) Citation

S, E., T, A., T, T., L, C., H, A., N, P., . . . C, F. (2025). Eye-Targeted A20 Gene Therapy Alleviates Ischemic Retinopathy by Reducing Pathologic Neovascularization, Gliosis, and Neuronal Apoptosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 39(22), e71226. https://doi.org/10.1096/fj.202500419R

Chicago Style (17th ed.) Citation

S, Essayagh, et al. "Eye-Targeted A20 Gene Therapy Alleviates Ischemic Retinopathy by Reducing Pathologic Neovascularization, Gliosis, and Neuronal Apoptosis." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 39, no. 22 (2025): e71226. https://doi.org/10.1096/fj.202500419R.

MLA (9th ed.) Citation

S, Essayagh, et al. "Eye-Targeted A20 Gene Therapy Alleviates Ischemic Retinopathy by Reducing Pathologic Neovascularization, Gliosis, and Neuronal Apoptosis." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 39, no. 22, 2025, p. e71226, https://doi.org/10.1096/fj.202500419R.